Vanguard Personalized Indexing Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,248
Closed -$945K 1380
2022
Q3
$945K Sell
6,248
-79
-1% -$11.9K 0.04% 505
2022
Q2
$922K Buy
6,327
+2,947
+87% +$429K 0.04% 506
2022
Q1
$401K Buy
3,380
+735
+28% +$87.2K 0.02% 914
2021
Q4
$365K Buy
2,645
+370
+16% +$51.1K 0.02% 812
2021
Q3
$316K Buy
+2,275
New +$316K 0.03% 744